应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02041 麦科田
待上市 08-28 16:00:00
15.420
+0.000
0.00%
最高
15.420
最低
15.420
成交量
0.00
今开
15.420
昨收
15.420
日振幅
0.00%
总市值
77.06亿
流通市值
73.90亿
总股本
5.00亿
成交额
0.00
换手率
0.00%
流通股本
4.79亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
麦科田启动港股IPO全球发售:2025年刚扭亏为盈 今年一季度又亏了 无基石护航 后市难料
新浪证券 · 08-28 18:12
麦科田启动港股IPO全球发售:2025年刚扭亏为盈 今年一季度又亏了 无基石护航 后市难料
新股消息 | 麦科田(02041)今日起招股, 2023-2025年间复合增长率达38.9%
智通财经 · 08-28 11:55
新股消息 | 麦科田(02041)今日起招股, 2023-2025年间复合增长率达38.9%
新股招股|麦科田今日起至9月2日招股,一手入场费1557.55 港元
老虎资讯综合 · 08-28 08:43
新股招股|麦科田今日起至9月2日招股,一手入场费1557.55 港元
麦科田今起招股,发售价15.42港元/股,预计9月7日挂牌上市
独角兽早知道 · 08-28 08:01
麦科田今起招股,发售价15.42港元/股,预计9月7日挂牌上市
美卡医疗启动全球发售:每股发售价15.42港元,拟募资净额约4.96亿港元
公告速递 · 08-28 06:28
美卡医疗启动全球发售:每股发售价15.42港元,拟募资净额约4.96亿港元
麦科田生物全球发售:发行3,891.1万股香港公开发售股份,发售价每股15.42港元
公告速递 · 08-28 06:19
麦科田生物全球发售:发行3,891.1万股香港公开发售股份,发售价每股15.42港元
深圳麦科田生物医疗技术股份有限公司(02041)启动港股招股 计划发行3,891.06万股H股
公告速递 · 08-28 06:05
深圳麦科田生物医疗技术股份有限公司(02041)启动港股招股 计划发行3,891.06万股H股
增长超130%!麦科田凭什么让港股“无法忽视“?
智通财经 · 08-25
增长超130%!麦科田凭什么让港股“无法忽视“?
IPO周报|本周4只新股申购,国内轴承制造龙头来了
澎湃新闻 · 08-24
IPO周报|本周4只新股申购,国内轴承制造龙头来了
新股消息 | 医疗器械商麦科田通过港交所聆讯 三大业务线全球布局、多品类领先
智通财经 · 08-22
新股消息 | 医疗器械商麦科田通过港交所聆讯 三大业务线全球布局、多品类领先
麦科田生物通过上市聆讯:第一季营收4.2亿 亏253万 高瓴是股东
雷递网 · 08-21
麦科田生物通过上市聆讯:第一季营收4.2亿 亏253万 高瓴是股东
公司概况
公司名称:
麦科田
所属市场:
SEHK
上市日期:
--
主营业务:
麦科田医疗是一家全球医疗器械提供商,产品组合包括生命支持、微创介入及体外诊断三大业务领域,产品遍及全球逾140个国家及地区,在中国已累计覆盖超过6,000家医院,包括约90%的三级甲等医院。
发行价格:
--
{"stockData":{"symbol":"02041","market":"HK","secType":"STK","nameCN":"麦科田","latestPrice":15.42,"timestamp":1787904000000,"preClose":15.42,"halted":9,"volume":0,"delay":0,"changeRate":0,"floatShares":479221686,"shares":499716086,"eps":0,"marketStatus":"待上市","change":0,"latestTime":"08-28 16:00:00","open":15.42,"high":15.42,"low":15.42,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788744600000},"marketStatusCode":8,"adr":0,"listingDate":1788710400000,"exchange":"SEHK","adjPreClose":15.42,"openAndCloseTimeList":[[1787880600000,1787889600000],[1787893200000,1787904000000]],"volumeRatio":0,"ipoDetail":{"name":"麦科田","exchange":"SEHK","listingDate":"2026-09-07","sharesOutstanding":499716086,"sharesFloat":479221686,"offerAmount":38910600,"priceRange":"15.42","market":"HK","openProspectusDate":"2026-08-28","openProspectusUrl":"https://ossnoticepdf.iqdii.com/stockdata/notice/02041/2026/2026082800010_c.pdf","purchaseBeginDate":"2026-08-28","purchaseEndDate":"2026-09-02","winningDate":"2026-09-04","currency":"HKD","minPurchaseQuantity":100,"peRate":153.59,"use":"1、约35.0%或173.7百万港元将用于正在进行和计划进行的研发,以进一步丰富公司的产品线,打造具有竞争力的产品组合;\n2、约20.0%或99.2百万港元将用于发展公司的制造中心,扩大公司的产能;\n3、约20.0%或99.2百万港元将用于进一步提高公司的销售和营销能力;\n4、约10.0%或49.6百万港元将用于资助在全球范围内进行潜在的战略投资和收购;\n5、约5.0%或24.8百万港元将用于升级公司的IT基础设施和数字平台;\n6、约10.0%或49.6百万港元将用于营运资金及其他一般企业用途。","industryId":"204005","industryName":"医疗保健","business":"公司是一家全球医疗器械提供商,可满足医疗机构内广泛的临床科室、病房和诊所以及社区卫生中心、检验机构和家庭护理场景的临床需求。","subscribed":42.82,"marketCap":8306000000,"minimumCapital":1557.55,"overAllotment":false,"lotSize":100,"issueOpenRate":0.1,"subscribeGear":"100,200,300,400,500,600,700,800,900,1000,1500,2000,2500,3000,3500,4000,4500,5000,6000,7000,8000,9000,10000,20000,30000,40000,50000,60000,70000,80000,90000,100000,200000,300000,400000,500000,600000,700000,800000,900000,1000000,1500000,1945500","issueRatio":0.1,"offeringMechanism":"B"},"greyMarketDetail":{"greyDate":"2026-09-04","greyDateTimestamp":1788451200000,"greyOpeningTime":1788509700000,"greyClosingTime":1788517800000,"showGreyQuote":false,"openProspectusDate":"2026-08-28","listingDate":"2026-09-07"},"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02041/wiki","defaultTab":"wiki","newsList":[{"id":"2662061434","title":"麦科田启动港股IPO全球发售:2025年刚扭亏为盈 今年一季度又亏了 无基石护航 后市难料","url":"https://stock-news.laohu8.com/highlight/detail?id=2662061434","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662061434?lang=zh_cn&edition=full","pubTime":"2026-08-28 18:12","pubTimestamp":1787911920,"startTime":"0","endTime":"0","summary":"8月28日,深圳麦科田生物医疗技术股份有限公司宣布启动港股全球发售,拟发行3891.06万股H股,发售价定为每股15.42港元,预计9月7日在港交所挂牌上市。但2026年第一季度的业绩又出现了反复。从“战略性亏损”到盈利再反复麦科田曾在2022年至2024年经历连续三年亏损。2025年的扭亏为盈,被解读为公司已跨越“战略性亏损”的临界点。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-08-28/doc-inipwhrr9070076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["FRHC","02041","BK4127","BK4585","VXUS","BK4588","KCAI","KCE","REDS","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662756053","title":"新股消息 | 麦科田(02041)今日起招股, 2023-2025年间复合增长率达38.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662756053","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662756053?lang=zh_cn&edition=full","pubTime":"2026-08-28 11:55","pubTimestamp":1787889311,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,8月28日,麦科田发布公告,公司拟全球发售3891.06万股股份,其中香港发售股份389.11万股,国际发售股份3501.95万股。麦科田预计于2026年9月7日在主板上市,摩根士丹利亚洲有限公司、华泰金融控股(香港)有限公司为联席保荐人。麦科田是一家全球医疗器械提供商,可满足医疗机构内广泛的临床科室、病房和诊所以及社区卫生中心、检验机构和家庭护理场景的临床需求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1487761.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02041","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107995485","title":"新股招股|麦科田今日起至9月2日招股,一手入场费1557.55 港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1107995485","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107995485?lang=zh_cn&edition=full","pubTime":"2026-08-28 08:43","pubTimestamp":1787877794,"startTime":"0","endTime":"0","summary":"每手100股H股,一手入场费1557.55 港元,预期H股将于2026年9月7日(星期一)挂牌。集团的收入由2023年的人民币13.13亿元增加至2025年的人民币16.19亿元,并由截至2025年3月31日止三个月的人民币3.55亿元进一步增加至2026年同期的人民币4.22亿元。于截至2026 年3月31日止三个月,集团取得净亏损人民币250万元,主要由于集团根据首次公开发售前购股权计划作出股份支付人民币2510万元及产生上市开支人民币1250万元。","market":"us","thumbnail":"https://community-static.tradeup.com/news/6a1fc8f3be741038c54e99953f811f82","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/6a1fc8f3be741038c54e99953f811f82"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3430ee0e05254278b5a3da84a7b77b4c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"新股招股|麦科田今日起至9月2日招股,一手入场费1557.55 港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662051903","title":"麦科田今起招股,发售价15.42港元/股,预计9月7日挂牌上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2662051903","media":"独角兽早知道","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662051903?lang=zh_cn&edition=full","pubTime":"2026-08-28 08:01","pubTimestamp":1787875260,"startTime":"0","endTime":"0","summary":"截至2026年3月31日,公司产品组合包括超过60种生命支持产品、110种微创介入产品及150种体外诊断产品,销往全球逾140个国家及地区。麦科田的市场地位,在多个细分领域均处领先位置。在全球药物输注市场中,麦科田以15%的份额排名第二。2025年,公司跻身中国血型检测设备市场前五名。经调整年内利润达1.29亿元。截至2026年3月31日,公司现金及现金等价物达3.21亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzU3MTY1MzExOQ==&mid=2247613092&idx=1&sn=96b3ea784f7b128f19318fab878d5d38&chksm=fd6853b20cada64a2fee87fb4167d7ebe0360e79400702fec8f860c2901e5d7f45083580c692&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["EWH","02041","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124306994","title":"美卡医疗启动全球发售:每股发售价15.42港元,拟募资净额约4.96亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1124306994","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124306994?lang=zh_cn&edition=full","pubTime":"2026-08-28 06:28","pubTimestamp":1787869714,"startTime":"0","endTime":"0","summary":"公司总部位于中国深圳,并在全球超过140个国家和地区开展业务。2026年第一季度的收入约为人民币4.22亿元,高于2025年同期的3.55亿元,但因股份支付及上市费用增加,产生净亏损约人民币0.03亿元。本次全球发售涵盖香港公开发售及国际发售,共计发行3,891.06万股H股,约占扩大后已发行股本的7.2%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美卡医疗启动全球发售:每股发售价15.42港元,拟募资净额约4.96亿港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124639329","title":"麦科田生物全球发售:发行3,891.1万股香港公开发售股份,发售价每股15.42港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1124639329","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124639329?lang=zh_cn&edition=full","pubTime":"2026-08-28 06:19","pubTimestamp":1787869147,"startTime":"0","endTime":"0","summary":"深圳麦科田生物医疗技术股份有限公司主要从事生命支持、微创介入和体外诊断等三大医疗器械业务,产品覆盖注射泵及输注工作站、麻醉机、微创介入耗材、检测分析仪与体外诊断试剂等领域。根据公告,2023年至2025年,公司收入分别为人民币13.133亿元、人民币13.993亿元和人民币16.192亿元,2025年较2024年增长23.2%。发行完成后,公司总股本将增至约5.39亿股。公司假设按每股15.42港元的发售价并扣除相关开支后,预期从全球发售获得的所得款项净额约为4.96亿港元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"麦科田生物全球发售:发行3,891.1万股香港公开发售股份,发售价每股15.42港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108927095","title":"深圳麦科田生物医疗技术股份有限公司(02041)启动港股招股 计划发行3,891.06万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=1108927095","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108927095?lang=zh_cn&edition=full","pubTime":"2026-08-28 06:05","pubTimestamp":1787868348,"startTime":"0","endTime":"0","summary":"2026年8月28日,深圳麦科田生物医疗技术股份有限公司在港交所披露《全球发售》公告,正式启动香港首次公开募股。本次全球发售总规模为38,910,600股H股。根据招股说明书,深圳麦科田生物医疗技术股份有限公司2025年全年实现收入16.19亿元人民币,符合港交所上市规则第8.05条市值╱收益测试中“最近一个财年收益不少于5亿港元”的要求。届时,深圳麦科田生物医疗技术股份有限公司将正式成为港股市场医械领域的新成员。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662207457","title":"增长超130%!麦科田凭什么让港股“无法忽视“?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662207457","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662207457?lang=zh_cn&edition=full","pubTime":"2026-08-25 09:26","pubTimestamp":1787621214,"startTime":"0","endTime":"0","summary":"近日赴港上市的麦科田医疗,恰好站上“出海”与“创新”这两大风口。2023至2025年,麦科田总营收分别为13.13亿元、13.99亿元和16.19亿元,年复合增长率约11%;2026年前3个月营收同比增长19.1%至4.22亿元。2025年经调整净利润达1.29亿元,2026年前三个月经调整利润3500万元,远超去年同期的1510万元,经调整期内利润增长超130%;经调整EBITDA亦增长至2.90亿元,2023-2025年间复合增长率达38.9%。小结行业政策红利与业绩拐点双重叠加,让麦科田的本次IPO成为一个颇具吸引力的投资窗口。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484786.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","VXUS","02041","KCAI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661908241","title":"IPO周报|本周4只新股申购,国内轴承制造龙头来了","url":"https://stock-news.laohu8.com/highlight/detail?id=2661908241","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661908241?lang=zh_cn&edition=full","pubTime":"2026-08-24 08:14","pubTimestamp":1787530440,"startTime":"0","endTime":"0","summary":"本周新股申购迎来4家细分领域头部公司。Wind资料显示,洛轴股份主营轴承及相关零部件的研发、生产和销售,是中国轴承行业规模最大的综合性轴承制造企业之一。上周,共有6只新股上市。本周,北交所将继续开审。上周,湖南裕能新能源电池材料股份有限公司首次递交港股招股书。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-08-24/doc-inipkmaa6265702.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-08-24/doc-inipkmaa6265702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IPOS","KCE","BK4127","REDS","02041","FRHC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661216385","title":"新股消息 | 医疗器械商麦科田通过港交所聆讯 三大业务线全球布局、多品类领先","url":"https://stock-news.laohu8.com/highlight/detail?id=2661216385","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661216385?lang=zh_cn&edition=full","pubTime":"2026-08-22 14:35","pubTimestamp":1787380509,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02041","09996","BK1583","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661296975","title":"麦科田生物通过上市聆讯:第一季营收4.2亿 亏253万 高瓴是股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2661296975","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661296975?lang=zh_cn&edition=full","pubTime":"2026-08-21 22:24","pubTimestamp":1787322277,"startTime":"0","endTime":"0","summary":"深圳麦科田生物医疗技术股份有限公司(简称:“麦科田生物”)今日通过上市聆讯,准备在港交所上市。","market":"us","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260821/6392294784340183528109647.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260821/6392294784340183528109647.jpeg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n34802/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["IPOS","02041"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"https://www.medcaptain.com","compareEarnings":[{"period":"1week","weight":-0.0163},{"period":"1month","weight":-0.0086},{"period":"3month","weight":0.016},{"period":"6month","weight":-0.0393},{"period":"1year","weight":0.0234},{"period":"ytd","weight":-0.0018}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"麦科田医疗是一家全球医疗器械提供商,产品组合包括生命支持、微创介入及体外诊断三大业务领域,产品遍及全球逾140个国家及地区,在中国已累计覆盖超过6,000家医院,包括约90%的三级甲等医院。","exchange":"SEHK","name":"麦科田","nameEN":"MEDCAPTAIN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"麦科田(02041)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供麦科田(02041)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"麦科田,02041,麦科田股票,麦科田股票老虎,麦科田股票老虎国际,麦科田行情,麦科田股票行情,麦科田股价,麦科田股市,麦科田股票价格,麦科田股票交易,麦科田股票购买,麦科田股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"麦科田(02041)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供麦科田(02041)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}